Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Portfolio News / Karina Tin July 20, 2020 Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Read More »
Arcus Biosciences and Gilead Sciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies Portfolio News / Karina Tin July 13, 2020 Arcus Biosciences and Gilead Sciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies Read More »
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock Portfolio News / Karina Tin July 8, 2020 Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock Read More »
Arcus Biosciences Appoints Bob Goeltz as Chief Financial Officer Portfolio News / Karina Tin July 7, 2020 Arcus Biosciences Appoints Bob Goeltz as Chief Financial Officer Read More »
Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor Portfolio News / Karina Tin June 22, 2020 Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor Read More »
Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials Portfolio News / Karina Tin June 19, 2020 Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials Read More »
Rapt Therapeutics Appoints Peter Svennilson to Board of Directors Portfolio News / Karina Tin June 18, 2020 Rapt Therapeutics Appoints Peter Svennilson to Board of Directors Read More »
Revolution Medicines Appoints Peter Svennilson to its Board of Directors Portfolio News / Karina Tin June 18, 2020 Revolution Medicines Appoints Peter Svennilson to its Board of Directors Read More »
Nurix Therapeutics Announces Addition of Immuno-Oncology Clinical Experts to its Management Team Portfolio News / Karina Tin June 16, 2020 Nurix Therapeutics Announces Addition of Immuno-Oncology Clinical Experts to its Management Team Read More »
Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock Portfolio News / Karina Tin June 16, 2020 Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock Read More »